StockData
Carlsmed, Inc. logo

Carlsmed, Inc. (CARL) stock

CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.37−0.37 (-2.09%)

Close on Nov 18, 2026Market cap $474.25MP/E –Yield –

Carlsmed operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Carlsmed's operating income for the twelve months ending Jun 30, 2026 was -$38.67M. For fiscal 2025 it was -$30.57M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$30.57M–
FY2024Dec 31, 2024-$24.12M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$11.04M–
Q1 FY2026Mar 31, 2026-$9.28M–
Q4 FY2025Dec 31, 2025-$9.32M–
Q3 FY2025Sep 30, 2025-$9.04M–
Q2 FY2025Jun 30, 2025-$6.50M–
Q1 FY2025Mar 31, 2025-$5.72M–
Q4 FY2024Dec 31, 2024-$4.70M–
Q3 FY2024Sep 30, 2024-$7.78M–
Q2 FY2024Jun 30, 2024-$6.32M–

More Carlsmed figures

See a number that looks wrong?